WhiteLab Genomics
Unleashing the potential of DNA and RNA based therapies using AI
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies. WhiteLab Genomics is a Y Combinator company (Winter 2022). YC-listed status: Active.
- Website
- whitelabgx.com
- Location
- Paris, Île-de-France, France; Boston, MA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- WhiteLab Genomics — AI platform that accelerates cell and gene therapy drug discovery through rational design of molecular constructs and vectors. · Saas · Enterprise
Links
- Y Combinator profileycombinator